Diabetic foot problems such as ulcerations, infections and gangrene are dreadful complications of diabetes mellitus and a major cause of hospitalization. Overall 15% of individuals with diabetes mellitus will have foot ulcers during their lifetime. Diabetic foot infected patients are usually prescribed with broad spectrum antibiotics. Our study was done to evaluate the sensitivity pattern of cephalosporins in diabetic foot patients and to assess their prescribing patterns. We carried out a prospective study in the surgery department of a tertiary care hospital on 77 patients who had diabetic foot infections. Prescribing patterns of cephalosporins and wound culture and sensitivity testing on these patients was studied for a period of 6 months. Staphylococcus aureus was the most common gram positive pathogen isolated, E.coli, Klebsiella, Pseudomonas and Citrobacter were the common gram negative organisms isolated. Ceftriaxone was the most commonly prescribed antibiotic. Sensitivity pattern showed that 41.5% of gram positive cocci and 25% of gram negative bacilli were sensitive to Ceftriaxone. Ceftriaxone in our study was found to be an effective drug provided appropriate barrier techniques were used to prevent nosocomial spread. Organisms which were originally sensitive developed resistance approximately in a span of two weeks, probably due to antibiotic pressure. Hence there should be an active infection control team which can monitor the prevalent organisms and their antibiograms and periodically inform the clinicians. The pharmacists should also be included in the team, apart from the microbiologist, the surgeon and the nursing staff.
INTRODUCTION
Diabetes, considered as a disease of developed countries, is one of the endocrine disorders that have reached epidemic proportions worldwide. 1 There are currently 285 million people living with diabetes worldwide, and the number of affected people is predicted to reach 438 million by 2030, 2 with 62 million diabetic individuals currently diagnosed with the disease in India. 3 It is predicted that by 2030 diabetes mellitus may afflict up to 79.4 million individuals in India as a consequence of longer life expectancy, sedentary lifestyle and changing dietary patterns. 4 Complications associated with diabetes arise chiefly from the disruption of the vascular system which can result in inadequate circulation to the peripheral body. This places the foot at higher risk of ulceration and infection. 1 Diabetic foot ulcer is a major complication of diabetes mellitus, and probably the major component of the diabetic foot. A series of multiple mechanisms, including decreased cell and growth factor response, leads to diminished peripheral blood flow and decreased local angiogenesis, all of which can contribute to lack of healing in persons with diabetic foot ulcers. The foot ulcer is a leading cause of hospital admissions for people with diabetes in the world and is a major morbidity associated with diabetes, often leading to pain, suffering, and a poor quality of life for patients. 5 Overall 15% of individuals with diabetes mellitus will have foot ulcer during their lifetime and in most developed countries, the annual incidence of foot ulceration amongst people with diabetes is about 2%. 6, 7 In these countries, diabetes is the most common cause of non-traumatic amputation; approximately 1% of people with diabetes suffer a lower-limb amputation.
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85% of diabetes-related lower extremity amputations are preceded by a foot ulcer. In developed countries one in every six people with diabetes will have an ulcer during their lifetime. 8 Diabetes and foot problems are almost synchronous. Pseudomonas spp., Enterococcus spp. and Proteus spp. are responsible for extensive tissue destruction with the poor blood circulation to the foot.
9 Today antimicrobials remain the first line therapy for conquering bacterial infections. Treatment with these drugs is considered as a two-edged sword. As antimicrobial agents have been misused or overused, bacteria have fought back with a selection process by which certain strains are no longer susceptible to one or more agents. Each new use of these drugs, in fact, contributes to evolution of resistant microorganisms. As a result bacteria that once seemed to be losing the battle for survival have reemerged to create therapeutic dilemmas with resulting increased risk of treatment failure and disease complications. 10 The cephalosporin antibiotics have become a major part of antibiotic formulary for hospitals in affluent countries. Clinicians choose empirical therapy with a cephalosporin whilst awaiting microbiological and other tests, since bacterial identification and antimicrobial testing usually requires 24-48 hr. The broad spectrum capability of these drugs, however, encourages rapid overgrowth of some microorganisms that are neither eliminated nor inhibited by therapy, as cephalosporins are not active against all the bacteria. These organisms not only have pathogenic potential, they may also be multiply resistant to antibiotics. There is evidence that cephalosporin usage is the most important factor in the selection and propagation of microorganisms such as Clostridium difficile, methicillin resistant Staphylococcus aureus, Penicillin-resistant Pneumococci, multiply resistant coliforms and vancomycinresistant Enterococci, the continuing increase of which threatens the future of antimicrobial therapy.
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Strict adherence and well accepted guidelines, along with caution in use of broad-spectrum antimicrobial agents, represents the best strategy for preventing the emergence and spread of nosocomial multidrug-resistant pathogens. 12 Foot infections, which account for more hospital admissions than any of the other long-term complications of diabetes, are associated with increasing morbidity and mortality in diabetic patients. However, nosocomial pathogens are playing an important role in increasing morbidity and mortality of diabetic foot infections. 13 Foot problems account for up to 15% of healthcare resources in developed countries and 40% in developing countries and anti-microbial resistance in the hospital setting has emerged as an important variable influencing patient outcomes and overall resource utilization. 8 Prescribing practices of surgeons has become a major factor in today's scenario for treating foot infections. Inappropriate use of cephalosporins has become a major problem in the treatment, as there has been marked increase in resistivity seen among bacterial pathogens due to over prescribing or under prescribing of antibiotics. Hence, an attempt was made here to study the prescribing patterns of cephalosporins by surgeons in the treatment of diabetic foot infections with a study on sensitivity testing and effect of nosocomial pathogens in a hospital set up.
MATERIALS AND METHODS
We performed a prospective 6 months study on 77 patients to know the prescribing, as well as the sensitivity patterns of Cephalosporins in patients with diabetic foot ulcers. This study was conducted in the inpatient Surgery Department of, a tertiary care hospital which provides specialized health care services to all strata of people in and around Bengaluru. The entire project was conducted according to the guidelines set by the Ethical Committee of the hospital. All the patients with Type 1 and Type 2 Diabetes between the ages of 40-80 years, admitted to the surgical department with a diabetic foot infection during the study period were included in the study. Diabetic foot infected patients prescribed with treatment other than Cephalosporins were excluded from the study. A total of 77 patients who met the study criteria, diagnosed with diabetic foot, gangrene and cellulitis were observed for the study and were identified from the surgical inpatient wards. Treatment charts of the patients were reviewed prospectively for the prescription patterns of cephalosporins by the clinicians and were followed up with culture and sensitivity reports. Data collected from each of the patients, included their demographic details, drug prescribed empirically, after first culture and subsequent repeat cultures and sensitivity reports. All the above data was recorded in a data collection form for further analysis and interpretation. The data of the first culture and sensitivity reports of 77 patients, repeat one-culture sensitivity reports of 48 patients and repeat two culture and sensitivity reports of 9 patients were collected. First culture and sensitivity reports were collected to determine the effect of empirical treatment. Repeat culture and sensitivity reports were collected to determine the effect of the cephalosporins and presence of nosocomial pathogens. Treatment failure was defined as any change in the antibiotic prescription given due to the presence of different organisms with differences in sensitivity on repeat culture performed. If the patient's ulcer was not healing, repeat procedures like debridement, amputation etc were one of the options considered. Cross-tabulation for SPSS (Statistical Package for Social Sciences) Software has been used to find the prescription pattern with organism isolated each time. Significance was reported by 95% CI (Confidence Interval) which was calculated by binomial probability method. Table 1 shows that most commonly prescribed cephalosporins empirically were ceftriaxone in 41 (53.24%) patients followed by cefoperazone + salbactum in 28 (36.36%) patients. Table 1 shows that, after first culture ceftriaxone was given to 26 (33.76%) patients and cefoperazone + salbactum to 19 (24.67%) patients. After the antibiograms, percentage of drugs other than cephalosporins prescribed were increased (Figure 1 ). After first culture other antibiotics prescribed were 14 (18.18%) followed by in repeat one 25 (52.08%) and in repeat two 3 (33.33%).
RESULT
Out of 307 antibiograms of the patients, 195 (63.51%) showed growth; of which 41 (21.02%) yielded grampositive cocci followed 128 (65.64%) gram-negative bacilli (enterobacteriaceae 95 (48.71%) and 26 (13.3%) polymicrobials. Gram-positive cocci isolated were enterococcus 23 (56%) followed by coagulase negative Staphlococcusaureus 12 (29.3%). Gram-negative bacilli isolated were E.coli 38 (29.7%) followed by Klebsiella 28 (21.9%). The prescribing pattern of drugs other than cephalosporins after each sensitivity testing. It clearly shows that after each sensitivity testing, the percentage of drugs prescribed other than cephalosporins had increased
Figure 2: Pie chart showing different types of diabetic foot infection
Among 77 patients, 40 (51.95%) patients were diagnosed with diabetic foot ulcer followed by 21 (27.27%) cellulitis and 16 (20.78%) gangrene
From the Figure 3 , E.coli was the most prevalent organism in diabetic foot infection in this hospital.
Out of 77, 30 (38.96%) patients managed with antibiotics alone, while 47 (61.04%) patients underwent surgical intervention with concomitant antibiotics. Debridement was the most frequent surgical intervention in 26 (33.76%) patients followed by toe disarticulation in 14 (18.18%) and amputation in 7 (9.09%) patients.
DISCUSSION
A total of 77 patients who fulfilled the inclusion and exclusion criteria and who were admitted to our study center were included in this study, which was carried out for a period of six months. Among the 77 patients with diabetic foot infections from surgical units, 70% were male and 30% were female. According to Llanes, male population accounts for more hospital admission than females in diabetic foot infections. 14 In our study 90.4% patients had type 2 diabetes and only 9.6% had type 1diabetes (Table 2) . We observed that 48.2% patients had ulcers followed by 27.27% with cellulitis and 20.78% with gangrene ( Figure   2 ). According to a similar study by Anandi C on patients with diabetic foot lesions, 56% had ulcer followed by 26.1% with cellulitis and 15.9% with gangrene. 15 The present study illustrated that the infection was due to gram-positive cocci, gram-negative bacilli and polymicrobials. Among these 65.6% gram-negative bacilli (enterobacteriaceae group 48.71%) followed by 21.02% gram-positive cocci and 14.87% polymicrobials were isolated. Out study revealed that E.coli (19.5%), Klebsiella (14.35%), Pseudomonas (10.8%) and Citrobacter (10.3%) were the most common gram-negative organisms isolated. Staphylococcus aureus (14.4%) and Enterococcus (11.8%) were the most common grampositive pathogen isolated in our study. These results were comparable with a similar study which was conducted in Bangalore by Vidya D et al, in diabetic foot infections where the most commonly isolated organisms were Staphylococcus aureus, Citrobacterspp, Pseudomonas spp, Enterococcus and Pneumococci. 16 According to Motta RN et al, enterobacteriaceae group (97.8%) were the most frequently isolated bacteria. 17 According to David Burgess S, Extended-Spectrum β-Lactamase (ESBL)-producing organisms are an increasing problem for practitioners dealing with infectious disease. Escherichia coli, Klebsiellapneumoniae and Klebsiellaoxytoca are the most common ESBLproducing pathogens. 18 Sensitivity testing was done for patients with gram-negative bacilli in diabetic foot infection at our study center and it was found that organisms showed increased resistance patterns to cephalosporins, while in case of infections due to gram-positive cocci, cephalosporins on them was not studied separately. According to the reporting at Inter science Conference on Antimicrobial Agents and Chemotherapy (ICAAC) conference, Extended Spectrum β-Lactamase (ESBLs) are β-lactamases that hydrolyze extended-spectrum cephalosporins with an oxyimino side chain. These cephalosporins include cefotaxim, ceftriaxone and ceftazidime, as well as the oxyimino-monobactamaztreonam. The clinical relevance of ESBLs has been well documented by numerous published case reports describing clinical failures with the use of third generation cephalosporins such as these oxyimino-cephalosporins (cefotaxime, ceftriaxone and ceftazidime) as well as with the use of cefoxetin and the fourth generation cephalosporin, cefepime. Thus, the problem of ESBLs is clinically important, yet remains relatively unappreciated by most clinicians. This is because many clinical microbiology laboratories continue to mistakenly report these gram-negative bacillary isolates as susceptible due to difficulties in identifying those isolates which possess this important beta-lactamases. 
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Figure 3: Bar diagram showing frequency distribution of organisms
Where, E.f-Enterococcus; Cps-Coagulase positive Staphylococcus aureus; CnsCoagulase negative Staphylococcus aureus; St-Streptococcus; C-Citrobacter; P-Psuedomonas; K-Klebsiella; E.c-E.coli; Pr-Proteus; Nlfgnb-Non-lactose fermentative gram-negative bacilli other than Pseudomonas; E-Enterobacter)
In the present study, injection ceftriaxone (53.24%) was the most commonly prescribed drug followed by injection cefoperazone + salbactum (36.36%) and injection cefotaxime (5.19% According to Mitchell SJ, resistance to third-generation cephalosporins in gram-negative nosocomial pathogen is a formidable problem, associated with adverse clinical outcomes and increased hospital costs. 20 According to Rahal JJ, extensive cephalosporin class restriction significantly reduced nosocomial, plasmidmediated, cephalosporin-resistant Klebsiella infection and colonization. 21 Nosocomial infection and surgical intervention like debridement, toe disarticulation and amputation probably were the factors contributing to treatment failure. Antibiotic pressure (prolonged use of antibiotics) may (Table 3 ) also contribute to treatment failure. Patients have to be counseled regarding care to be taken to prevent foot infections, as diabetic patients are vulnerable to foot infections. 
CONCLUSION
In our study, we found that, gram-negative bacilli showed increased resistance pattern to cephalosporins, while in case of infections due to gram-positive cocci, cephalosporins were effective. Ceftriaxone is an effective drug provided appropriate barrier techniques are implemented in preventing nosocomial spread. Organisms which were originally sensitive, developed resistance approximately in a span of two weeks, which can probably be due to antibiotic pressure. Treatment for longer duration may result in drug resistance. Hence treatment failure can probably be due to nosocomial infection and antibiotic pressure. Hence, there should be an active infection control team, which can monitor the prevalent organisms and their antibiograms, and periodically inform the clinicians. The pharmacist should also be included in the team apart from microbiologist, surgeon and nursing staff.
CONFLICT OF INTEREST
Authors declared no conflict of interest
ACKNOWLEDGMENT
We are thankful to the principal and the staff of VIPS and KIMS for permitting us to carry out the study, collect data and for all the cooperation extended while carrying out the study. Funding-no funding sources Ethical approval-The study was approved by the institutional ethics committee.
